Over 90% of clinical trials exclude the majority of the world's population, leaving $100 billion in unrealized value every year. The future of pharma is not just discovering new molecules, but unlocking the full value of those we already have.
Revenue gap: $50M+/year from premium pricing
Time-to-market delay: 6–12 months vs. AI-enabled peers
This approach closes these gaps in <18 months via sovereign data generation.
Sarah Miller(971) 56 222 3782sarah@lifex.ai